IN2013MU02110A - - Google Patents
Info
- Publication number
- IN2013MU02110A IN2013MU02110A IN2110MU2013A IN2013MU02110A IN 2013MU02110 A IN2013MU02110 A IN 2013MU02110A IN 2110MU2013 A IN2110MU2013 A IN 2110MU2013A IN 2013MU02110 A IN2013MU02110 A IN 2013MU02110A
- Authority
- IN
- India
- Prior art keywords
- preparing
- pharmaceutical compositions
- present
- provides
- dicyclomine
- Prior art date
Links
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 4
- 229940000425 combination drug Drugs 0.000 abstract 2
- XLMALTXPSGQGBX-GCJKJVERSA-N dextropropoxyphene Chemical compound C([C@](OC(=O)CC)([C@H](C)CN(C)C)C=1C=CC=CC=1)C1=CC=CC=C1 XLMALTXPSGQGBX-GCJKJVERSA-N 0.000 abstract 2
- 229960004193 dextropropoxyphene Drugs 0.000 abstract 2
- CURUTKGFNZGFSE-UHFFFAOYSA-N dicyclomine Chemical compound C1CCCCC1C1(C(=O)OCCN(CC)CC)CCCCC1 CURUTKGFNZGFSE-UHFFFAOYSA-N 0.000 abstract 2
- 229960002777 dicycloverine Drugs 0.000 abstract 2
- 239000008203 oral pharmaceutical composition Substances 0.000 abstract 2
- 229960005489 paracetamol Drugs 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000007787 solid Substances 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000002921 anti-spasmodic effect Effects 0.000 abstract 1
- 239000000812 cholinergic antagonist Substances 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention provides a process of preparing the solid oral pharmaceutical compositions comprising fixed dose combination of acetaminophen, dicyclomine and dextropropoxyphene or salts thereof. In particular, the present invention provides a process of preparing the solid oral pharmaceutical compositions comprising fixed dose combination of acetaminophen, dicyclomine and dextropropoxyphene or salts thereof, one or more alkalizers, and other pharmaceutically acceptable excipients. The compositions of the present invention exhibit improved/faster dissolution profile of one or more active ingredients. The invention further provides a process of preparing the process of preparing said pharmaceutical compositions and their use as antispasmodic.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB2014/062251 WO2014203140A1 (en) | 2013-06-22 | 2014-06-16 | Solid oral pharmaceutical compositions comprising fixed dose combination of acetaminophen, dicyclomine and dextropropoxyphene or salts thereof |
| IN2110MU2013 IN2013MU02110A (en) | 2013-06-22 | 2014-06-16 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2110MU2013 IN2013MU02110A (en) | 2013-06-22 | 2014-06-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013MU02110A true IN2013MU02110A (en) | 2015-06-05 |
Family
ID=54396395
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2110MU2013 IN2013MU02110A (en) | 2013-06-22 | 2014-06-16 |
Country Status (1)
| Country | Link |
|---|---|
| IN (1) | IN2013MU02110A (en) |
-
2014
- 2014-06-16 IN IN2110MU2013 patent/IN2013MU02110A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12020500066A1 (en) | Carboxamides as modulators of sodium channels | |
| PH12015502002B1 (en) | Tripeptide epoxy ketone protease inhibitors | |
| SG10201810985XA (en) | Tofacitinib oral sustained release dosage forms | |
| MX2016012574A (en) | Substituted heteroaryl compounds and methods of use. | |
| IN2013MU03583A (en) | ||
| JO3326B1 (en) | Tripeptide Epoxy Ketone Protease Inhibitors | |
| CR20170604A (en) | ORAL SOLID FORMULATION CONTAINING IRINOTECAN AND METHOD OF PREPARATION OF THE SAME | |
| MX2016014859A (en) | Pharmaceutical compositions comprising danirixin for treating infectious diseases. | |
| PH12016502233A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine | |
| MX2016006087A (en) | Rapidly disintegrating formulations and methods of use. | |
| MX364652B (en) | Pharmaceutical formulation comprising ciclesonide. | |
| PH12016502236A1 (en) | (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine | |
| CL2016000182A1 (en) | Stable anti-tuberculosis pharmaceutical composition in a form of a coated tablet comprising isoniazid granules and rifapentin granules and their preparation process | |
| GR1008228B (en) | Pharmaceutical composition comprising a dual reuptake inhibitor and method for the preparation thereof | |
| SA516370446B1 (en) | Anti-tuberculosis stable pharmaceutical composition in a form of a dispersible tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation | |
| MX390369B (en) | Tripeptide epoxy ketone protease inhibitors | |
| IN2013MU02110A (en) | ||
| IN2013MU03428A (en) | ||
| IN2013MU02111A (en) | ||
| PH12020550597A1 (en) | Formulation having improved hygroscopic property and dissolution rate comprising telmisartan or its pharmaceutically acceptable salt | |
| IN2013MU03639A (en) | ||
| MY194591A (en) | Pharmaceutical combination formulation | |
| WO2014141298A3 (en) | Stable pharmaceutical composition of fingolimod | |
| IN2013MU02059A (en) | ||
| IN2013MU01243A (en) |